sulfasalazine has been researched along with Cholangiocarcinoma in 1 studies
Sulfasalazine: A drug that is used in the management of inflammatory bowel diseases. Its activity is generally considered to lie in its metabolic breakdown product, 5-aminosalicylic acid (see MESALAMINE) released in the colon. (From Martindale, The Extra Pharmacopoeia, 30th ed, p907)
sulfasalazine : An azobenzene consisting of diphenyldiazene having a carboxy substituent at the 4-position, a hydroxy substituent at the 3-position and a 2-pyridylaminosulphonyl substituent at the 4'-position.
Cholangiocarcinoma: A malignant tumor arising from the epithelium of the BILE DUCTS.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Thanee, M | 1 |
| Loilome, W | 1 |
| Techasen, A | 1 |
| Sugihara, E | 1 |
| Okazaki, S | 1 |
| Abe, S | 1 |
| Ueda, S | 1 |
| Masuko, T | 1 |
| Namwat, N | 1 |
| Khuntikeo, N | 1 |
| Titapun, A | 1 |
| Pairojkul, C | 1 |
| Saya, H | 1 |
| Yongvanit, P | 1 |
1 other study available for sulfasalazine and Cholangiocarcinoma
| Article | Year |
|---|---|
CD44 variant-dependent redox status regulation in liver fluke-associated cholangiocarcinoma: A target for cholangiocarcinoma treatment.
Topics: Animals; Autophagy; Carcinogenesis; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cholangioca | 2016 |